Report Details

Product Image
Medical Devices & Diagnostics

Global Hemostats Market Size, Share, Growth Analysis, Surgical Bleeding Control Trends, Product Innovation, Industry Outlook and Forecast 2025–2035

$2999

Hemostats market analysis covering growth trends, product innovation, surgical applications, competitive landscape, and forecast through 2035.

SKU: 9021    Pages: 200   Format: PDF   Delivery: Upto 24 to 48 hrs

Introduction

  • The Global Hemostats Market is estimated to be valued at USD 3.92 billion in 2025 and is projected to reach approximately USD 7.40 billion by 2035, expanding at a CAGR of 6.55% during the forecast period. Market growth is being driven by the increasing volume of surgical procedures, rising prevalence of trauma injuries, and growing demand for advanced bleeding control solutions across healthcare facilities worldwide.
  • The market is witnessing strong adoption of innovative hemostatic agents, sealants, and absorbable products that help reduce surgical complications, shorten procedure times, and improve patient recovery outcomes. Advancements in biomaterial technologies and the growing preference for minimally invasive surgeries are further supporting the demand for effective hemostatic products.
  •  Rising healthcare investments, expanding hospital infrastructure, and increasing awareness regarding blood loss management are creating new growth opportunities for manufacturers. In addition, continuous product development, strategic collaborations, and the growing utilization of hemostats in cardiovascular, orthopedic, neurological, and general surgical procedures are expected to strengthen market expansion over the next decade.

Porter’s Five Forces Analysis – Global Hemostats Market

• Threat of New Entrants – Low to Moderate

  • Entry into the hemostats market requires significant investment in clinical research, product validation, regulatory approvals, and manufacturing capabilities.
  • Established brands benefit from strong relationships with hospitals, surgical centers, and healthcare procurement networks, creating barriers for new participants.
  • Increasing regulatory scrutiny for surgical products and biologic materials further limits the pace of new market entry.

• Bargaining Power of Suppliers – Moderate

  • Suppliers providing specialized biomaterials, collagen, gelatin, oxidized cellulose, and thrombin-based components hold moderate influence due to quality and compliance requirements.
  • Large manufacturers often maintain diversified sourcing strategies and long-term supplier agreements, reducing supply-side risks.
  • Ongoing advancements in biomaterial science are encouraging the development of alternative raw material sources, improving supply chain flexibility.

• Bargaining Power of Buyers – Moderate to High

  • Hospitals, healthcare systems, and group purchasing organizations have substantial negotiating power due to bulk procurement practices.
  • Buyers increasingly evaluate products based on clinical effectiveness, cost efficiency, patient outcomes, and reimbursement considerations.
  • Growing competition among hemostat manufacturers provides healthcare providers with a wider range of product options and pricing alternatives.

• Threat of Substitutes – Moderate

  • Traditional surgical techniques such as sutures, ligatures, electrocautery devices, and mechanical bleeding control methods remain available alternatives in certain procedures.
  • However, advanced hemostatic products offer faster bleeding control, reduced operating time, and improved surgical efficiency, supporting their continued adoption.
  • The increasing complexity of surgical interventions is strengthening demand for specialized hemostatic solutions over conventional methods.

• Competitive Rivalry – High

  • The market is highly competitive, with leading medical technology companies focusing on innovation, product differentiation, clinical evidence generation, and geographic expansion.
  • Companies are actively investing in next-generation hemostatic agents, combination products, and bioactive technologies to strengthen market positioning.
  • Strategic partnerships, acquisitions, and new product launches continue to intensify competition as manufacturers seek to expand their surgical care portfolios and global presence.

Global Hemostats Market – Top 7 Segments with Sub-Segments

1. By Product Type

1.1 Thrombin-Based Hemostats
1.1.1 Human Thrombin
1.1.2 Bovine Thrombin
1.1.3 Recombinant Thrombin
1.1.4 Others

1.2 Oxidized Regenerated Cellulose-Based Hemostats
1.2.1 Woven ORC Hemostats
1.2.2 Non-Woven ORC Hemostats
1.2.3 ORC Powder
1.2.4 Others

1.3 Gelatin-Based Hemostats
1.3.1 Gelatin Sponge
1.3.2 Gelatin Matrix
1.3.3 Gelatin Powder
1.3.4 Others

1.4 Collagen-Based Hemostats
1.4.1 Collagen Sponge
1.4.2 Collagen Pad
1.4.3 Collagen Powder
1.4.4 Others

1.5 Combination Hemostats
1.5.1 Gelatin-Thrombin Hemostats
1.5.2 Collagen-Thrombin Hemostats
1.5.3 Cellulose-Thrombin Hemostats
1.5.4 Others

1.6 Others
1.6.1 Fibrin-Based Hemostats
1.6.2 Polysaccharide-Based Hemostats
1.6.3 Chitosan-Based Hemostats
1.6.4 Synthetic Hemostats

 

2. By Form

2.1 Sponge
2.1.1 Gelatin Sponge
2.1.2 Collagen Sponge
2.1.3 Absorbable Sponge
2.1.4 Others

2.2 Powder
2.2.1 Hemostatic Powder
2.2.2 Flowable Powder
2.2.3 Sprayable Powder
2.2.4 Others

2.3 Matrix / Gel
2.3.1 Flowable Hemostatic Matrix
2.3.2 Gelatin Matrix
2.3.3 Thrombin Matrix
2.3.4 Others

2.4 Sheet / Pad
2.4.1 Cellulose Sheet
2.4.2 Collagen Pad
2.4.3 Fibrin Pad
2.4.4 Others

2.5 Liquid / Spray
2.5.1 Thrombin Solution
2.5.2 Hemostatic Spray
2.5.3 Sealant-Based Liquid Hemostats
2.5.4 Others

 

3. By Material

3.1 Gelatin
3.1.1 Porcine Gelatin
3.1.2 Bovine Gelatin
3.1.3 Synthetic Gelatin-Based Material
3.1.4 Others

3.2 Collagen
3.2.1 Bovine Collagen
3.2.2 Porcine Collagen
3.2.3 Recombinant Collagen
3.2.4 Others

3.3 Oxidized Regenerated Cellulose
3.3.1 Standard ORC
3.3.2 Advanced ORC
3.3.3 ORC Powder
3.3.4 Others

3.4 Thrombin
3.4.1 Human-Derived Thrombin
3.4.2 Bovine-Derived Thrombin
3.4.3 Recombinant Thrombin
3.4.4 Others

3.5 Fibrin
3.5.1 Human Fibrin
3.5.2 Fibrin Patch Material
3.5.3 Fibrin Sealant Material
3.5.4 Others

3.6 Others
3.6.1 Chitosan
3.6.2 Polysaccharide
3.6.3 Synthetic Polymers
3.6.4 Mineral-Based Materials

 

4. By Application

4.1 General Surgery
4.1.1 Abdominal Surgery
4.1.2 Gastrointestinal Surgery
4.1.3 Hernia Repair
4.1.4 Soft Tissue Surgery
4.1.5 Others

4.2 Cardiovascular Surgery
4.2.1 Coronary Artery Bypass Grafting
4.2.2 Valve Surgery
4.2.3 Vascular Repair
4.2.4 Aortic Surgery
4.2.5 Others

4.3 Orthopedic Surgery
4.3.1 Joint Replacement Surgery
4.3.2 Spine Surgery
4.3.3 Trauma Surgery
4.3.4 Bone Reconstruction
4.3.5 Others

4.4 Neurosurgery
4.4.1 Cranial Surgery
4.4.2 Spinal Neurosurgery
4.4.3 Tumor Resection
4.4.4 Others

4.5 Gynecological Surgery
4.5.1 Hysterectomy
4.5.2 Cesarean Section
4.5.3 Pelvic Surgery
4.5.4 Others

4.6 Urological Surgery
4.6.1 Prostate Surgery
4.6.2 Kidney Surgery
4.6.3 Bladder Surgery
4.6.4 Others

4.7 Dental & Oral Surgery
4.7.1 Tooth Extraction
4.7.2 Periodontal Surgery
4.7.3 Maxillofacial Surgery
4.7.4 Others

4.8 Trauma & Emergency Care
4.8.1 Accident & Injury Management
4.8.2 Emergency Bleeding Control
4.8.3 Military / Battlefield Trauma Care
4.8.4 Others

 

5. By Usability

5.1 Absorbable Hemostats
5.1.1 Gelatin Absorbable Hemostats
5.1.2 Collagen Absorbable Hemostats
5.1.3 Cellulose Absorbable Hemostats
5.1.4 Fibrin Absorbable Hemostats
5.1.5 Others

5.2 Non-Absorbable Hemostats
5.2.1 Hemostatic Dressings
5.2.2 External Hemostatic Pads
5.2.3 Trauma Hemostatic Products
5.2.4 Others

 

6. By End User

6.1 Hospitals
6.1.1 Public Hospitals
6.1.2 Private Hospitals
6.1.3 Multi-Specialty Hospitals
6.1.4 Surgical Hospitals

6.2 Ambulatory Surgical Centers
6.2.1 Single-Specialty ASCs
6.2.2 Multi-Specialty ASCs
6.2.3 Outpatient Surgery Centers
6.2.4 Others

6.3 Specialty Clinics
6.3.1 Dental Clinics
6.3.2 Orthopedic Clinics
6.3.3 ENT Clinics
6.3.4 Others

6.4 Trauma & Emergency Care Centers
6.4.1 Level I Trauma Centers
6.4.2 Level II Trauma Centers
6.4.3 Emergency Departments
6.4.4 Others

6.5 Military & Defense Medical Units
6.5.1 Field Hospitals
6.5.2 Military Trauma Units
6.5.3 Combat Emergency Care Units
6.5.4 Others

 

7. By Region

7.1 North America
7.1.1 U.S.
7.1.2 Canada
7.1.3 Mexico

7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 U.K.
7.2.4 Italy
7.2.5 Spain
7.2.6 Netherlands
7.2.7 Rest of Europe

7.3 Asia Pacific
7.3.1 China
7.3.2 India
7.3.3 Japan
7.3.4 South Korea
7.3.5 Australia
7.3.6 Malaysia
7.3.7 Indonesia
7.3.8 Vietnam
7.3.9 Rest of Asia Pacific

7.4 Latin America
7.4.1 Brazil
7.4.2 Argentina
7.4.3 Rest of Latin America

7.5 Middle East & Africa
7.5.1 Saudi Arabia
7.5.2 UAE
7.5.3 South Africa
7.5.4 Israel
7.5.5 Rest of Middle East & Africa

Table 1 : GLOBAL HEMOSTATS MARKET SNAPSHOT (2025–2035)

Metrics

Value

Market Name

Global Hemostats Market

Industry

Medical Devices Industry

Market Size (2025)

USD 3.92 Billion

Forecast Market Size (2035)

USD 7.40 Billion

CAGR (2025–2035)

6.55%

Base Year

2025

Historical Period

2020–2024

Forecast Period

2025–2035

Largest Market Region

North America

Fastest Growing Region

Asia Pacific

Leading Product Segment

Thrombin-Based Hemostats

Major End User

Hospitals

Top of Form

Source: Primary Research and Secondary Research Analysis

Global Hemostats Market – 100 Key Players in 10 Chapters

Chapter 01: Global Leading Hemostats Companies

  1. Johnson & Johnson Services, Inc. / Ethicon
  2. Baxter International Inc.
  3. Pfizer Inc.
  4. B. Braun SE
  5. Becton, Dickinson and Company
  6. Teleflex Incorporated
  7. Integra LifeSciences Holdings Corporation
  8. Medtronic plc
  9. Stryker Corporation
  10. Artivion, Inc. / CryoLife

Chapter 02: Advanced Surgical Hemostats & Sealants Companies

  1. CSL Behring
  2. Grifols, S.A.
  3. Octapharma AG
  4. Takeda Pharmaceutical Company Limited
  5. Kedrion Biopharma Inc.
  6. Advanced Medical Solutions Group plc
  7. Corza Medical
  8. Hemostasis, LLC
  9. Biom’up
  10. Marine Polymer Technologies, Inc.

Chapter 03: Topical Hemostatic Agents & Surgical Products Companies

  1. Medline Industries, LP
  2. Zimmer Biomet Holdings, Inc.
  3. Anika Therapeutics, Inc.
  4. Aroa Biosurgery Limited
  5. Tissuemed Ltd.
  6. Grena Ltd.
  7. LifeBond Ltd.
  8. Cresilon, Inc.
  9. RevMedx, Inc.
  10. Arch Therapeutics, Inc.

Chapter 04: Hemostatic Dressings & Trauma Care Companies

  1. HemCon Medical Technologies Inc.
  2. QuikClot / Z-Medica, LLC
  3. SAM Medical Products
  4. H&H Medical Corporation
  5. North American Rescue, LLC
  6. Safeguard Medical
  7. Celox Medical
  8. PerSys Medical
  9. TyTek Medical Inc.
  10. Tactical Medical Solutions, LLC

Chapter 05: Wound Care & Bleeding Control Product Companies

  1. Smith & Nephew plc
  2. 3M Company
  3. Mölnlycke Health Care AB
  4. ConvaTec Group plc
  5. Coloplast A/S
  6. Hollister Incorporated
  7. Paul Hartmann AG
  8. Lohmann & Rauscher GmbH & Co. KG
  9. DermaRite Industries, LLC
  10. Winner Medical Co., Ltd.

Chapter 06: Biologic, Fibrin & Plasma-Derived Hemostats Companies

  1. LFB S.A.
  2. Shanghai RAAS Blood Products Co., Ltd.
  3. China Biologic Products Holdings, Inc.
  4. Biotest AG
  5. Green Cross Corporation / GC Biopharma
  6. Hualan Biological Engineering Inc.
  7. Sanquin Plasma Products B.V.
  8. Japan Blood Products Organization
  9. ADMA Biologics, Inc.
  10. Kamada Ltd.

Chapter 07: Surgical Adhesives, Sealants & Biosurgery Companies

  1. CryoLife Europa Ltd.
  2. Polyganics B.V.
  3. Adhesys Medical GmbH
  4. Gecko Biomedical
  5. Tissium SA
  6. Sealantis Ltd.
  7. Cohera Medical, Inc.
  8. Meyer-Haake GmbH
  9. Peters Surgical
  10. Grena Biomed Limited

Chapter 08: Asia-Pacific Hemostats & Surgical Consumables Companies

  1. Terumo Corporation
  2. Nipro Corporation
  3. Olympus Corporation
  4. Gunze Limited
  5. JMS Co., Ltd.
  6. Daewoong Pharmaceutical Co., Ltd.
  7. Samyang Holdings Corporation
  8. Beijing Datsing Bio-Tech Co., Ltd.
  9. Hangzhou Singclean Medical Products Co., Ltd.
  10. Guangzhou Wondfo Biotech Co., Ltd.

Chapter 09: India, China & Emerging Market Surgical Product Companies

  1. Meril Life Sciences Pvt. Ltd.
  2. Healthium Medtech Limited
  3. Sutures India Pvt. Ltd.
  4. Dolphin Sutures
  5. Lotus Surgicals Pvt. Ltd.
  6. Unisur Lifecare Pvt. Ltd.
  7. Futura Surgicare Pvt. Ltd.
  8. Shandong Weigao Group Medical Polymer Co., Ltd.
  9. Lepu Medical Technology Co., Ltd.
  10. MicroPort Scientific Corporation

Chapter 10: Regional & Emerging Surgical / Wound Care Companies

  1. Unilene S.A.C. / Unilene
  2. Universal Sutures
  3. Assut Europe S.p.A.
  4. DemeTECH Corporation
  5. Internacional Farmacéutica S.A. de C.V.
  6. Betatech Medical
  7. Katsan Medical Devices
  8. Dolphin Hemostats
  9. Orion Sutures India Pvt. Ltd.
  10. Vitrex Medical A/S
  1. INTRODUCTION

1.1 Market Definition
1.2 Market Scope
1.3 Research Objectives
1.4 Market Assumptions
1.5 Currency Considered
1.6 Stakeholders
1.7 Executive Summary

  1. RESEARCH METHODOLOGY

2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
2.4 Data Collection Techniques
2.5 Market Size Estimation
2.6 Forecasting Methodology
2.7 Data Triangulation
2.8 Limitations of the Study

  1. MARKET DYNAMICS

3.1 Market Overview
3.2 Market Drivers
3.3 Market Restraints
3.4 Market Opportunities
3.5 Market Challenges
3.6 Emerging Trends
3.7 Impact Analysis of Macroeconomic Factors
3.8 Regulatory Framework Analysis

  1. MARKET FACTOR ANALYSIS

4.1 Value Chain Analysis
4.2 Supply Chain Analysis
4.3 Pricing Analysis
4.4 Technology Landscape
4.5 Product Benchmarking Analysis
4.6 Patent Analysis
4.7 Investment Analysis

  1. PORTER'S FIVE FORCES ANALYSIS

5.1 Threat of New Entrants
5.2 Bargaining Power of Suppliers
5.3 Bargaining Power of Buyers
5.4 Threat of Substitutes
5.5 Competitive Rivalry

  1. GLOBAL HEMOSTATS MARKET, BY PRODUCT TYPE

6.1 Overview
6.2 Thrombin-Based Hemostats
6.2.1 Human Thrombin
6.2.2 Bovine Thrombin
6.2.3 Recombinant Thrombin
6.2.4 Others

6.3 Oxidized Regenerated Cellulose-Based Hemostats
6.3.1 Woven ORC Hemostats
6.3.2 Non-Woven ORC Hemostats
6.3.3 ORC Powder
6.3.4 Others

6.4 Gelatin-Based Hemostats
6.4.1 Gelatin Sponge
6.4.2 Gelatin Matrix
6.4.3 Gelatin Powder
6.4.4 Others

6.5 Collagen-Based Hemostats
6.5.1 Collagen Sponge
6.5.2 Collagen Pad
6.5.3 Collagen Powder
6.5.4 Others

6.6 Combination Hemostats
6.6.1 Gelatin-Thrombin Hemostats
6.6.2 Collagen-Thrombin Hemostats
6.6.3 Cellulose-Thrombin Hemostats
6.6.4 Others

6.7 Others
6.7.1 Fibrin-Based Hemostats
6.7.2 Polysaccharide-Based Hemostats
6.7.3 Chitosan-Based Hemostats
6.7.4 Synthetic Hemostats

  1. GLOBAL HEMOSTATS MARKET, BY FORM

7.1 Overview
7.2 Sponge
7.3 Powder
7.4 Matrix / Gel
7.5 Sheet / Pad
7.6 Liquid / Spray

  1. GLOBAL HEMOSTATS MARKET, BY MATERIAL

8.1 Overview
8.2 Gelatin
8.3 Collagen
8.4 Oxidized Regenerated Cellulose
8.5 Thrombin
8.6 Fibrin
8.7 Others

  1. GLOBAL HEMOSTATS MARKET, BY APPLICATION

9.1 Overview
9.2 General Surgery
9.3 Cardiovascular Surgery
9.4 Orthopedic Surgery
9.5 Neurosurgery
9.6 Gynecological Surgery
9.7 Urological Surgery
9.8 Dental & Oral Surgery
9.9 Trauma & Emergency Care

  1. GLOBAL HEMOSTATS MARKET, BY USABILITY

10.1 Overview
10.2 Absorbable Hemostats
10.3 Non-Absorbable Hemostats

  1. GLOBAL HEMOSTATS MARKET, BY END USER

11.1 Overview
11.2 Hospitals
11.3 Ambulatory Surgical Centers
11.4 Specialty Clinics
11.5 Trauma & Emergency Care Centers
11.6 Military & Defense Medical Units

  1. GLOBAL HEMOSTATS MARKET, BY REGION

12.1 Overview
12.2 North America
12.2.1 U.S.
12.2.2 Canada
12.2.3 Mexico

12.3 Europe
12.3.1 Germany
12.3.2 France
12.3.3 U.K.
12.3.4 Italy
12.3.5 Spain
12.3.6 Netherlands
12.3.7 Rest of Europe

12.4 Asia Pacific
12.4.1 China
12.4.2 India
12.4.3 Japan
12.4.4 South Korea
12.4.5 Australia
12.4.6 Malaysia
12.4.7 Indonesia
12.4.8 Vietnam
12.4.9 Rest of Asia Pacific

12.5 Latin America
12.5.1 Brazil
12.5.2 Argentina
12.5.3 Rest of Latin America

12.6 Middle East & Africa
12.6.1 Saudi Arabia
12.6.2 UAE
12.6.3 South Africa
12.6.4 Israel
12.6.5 Rest of Middle East & Africa

  1. COMPETITIVE LANDSCAPE

13.1 Vendor Landscape
13.2 Market Share Analysis
13.3 Competitive Benchmarking
13.4 Strategic Developments
13.5 Mergers & Acquisitions
13.6 Partnerships & Collaborations
13.7 New Product Launches
13.8 Competitive Dashboard

  1. COMPANY PROFILES

14.1 Chapter 01: Global Leading Hemostats Companies

14.2 Chapter 02: Advanced Surgical Hemostats & Sealants Companies

14.3 Chapter 03: Topical Hemostatic Agents & Surgical Products Companies
14.4 Chapter 04: Hemostatic Dressings & Trauma Care Companies
14.5 Chapter 05: Wound Care & Bleeding Control Product Companies
14.6 Chapter 06: Biologic, Fibrin & Plasma-Derived Hemostats Companies
14.7 Chapter 07: Surgical Adhesives, Sealants & Biosurgery Companies
14.8 Chapter 08: Asia-Pacific Hemostats & Surgical Consumables Companies
14.9 Chapter 09: India, China & Emerging Market Surgical Product Companies
14.10 Chapter 10: Regional & Emerging Surgical / Wound Care Companies

  1. CONCLUSION AND STRATEGIC RECOMMENDATIONS

15.1 Key Findings
15.2 Strategic Recommendations
15.3 Future Market Outlook
15.4 Growth Opportunities

  1. APPENDIX

16.1 Abbreviations
16.2 List of Tables
16.3 List of Figures
16.4 References

Global Hemostats Market – Top 7 Segments with Sub-Segments

1. By Product Type

1.1 Thrombin-Based Hemostats
1.1.1 Human Thrombin
1.1.2 Bovine Thrombin
1.1.3 Recombinant Thrombin
1.1.4 Others

1.2 Oxidized Regenerated Cellulose-Based Hemostats
1.2.1 Woven ORC Hemostats
1.2.2 Non-Woven ORC Hemostats
1.2.3 ORC Powder
1.2.4 Others

1.3 Gelatin-Based Hemostats
1.3.1 Gelatin Sponge
1.3.2 Gelatin Matrix
1.3.3 Gelatin Powder
1.3.4 Others

1.4 Collagen-Based Hemostats
1.4.1 Collagen Sponge
1.4.2 Collagen Pad
1.4.3 Collagen Powder
1.4.4 Others

1.5 Combination Hemostats
1.5.1 Gelatin-Thrombin Hemostats
1.5.2 Collagen-Thrombin Hemostats
1.5.3 Cellulose-Thrombin Hemostats
1.5.4 Others

1.6 Others
1.6.1 Fibrin-Based Hemostats
1.6.2 Polysaccharide-Based Hemostats
1.6.3 Chitosan-Based Hemostats
1.6.4 Synthetic Hemostats

 

2. By Form

2.1 Sponge
2.1.1 Gelatin Sponge
2.1.2 Collagen Sponge
2.1.3 Absorbable Sponge
2.1.4 Others

2.2 Powder
2.2.1 Hemostatic Powder
2.2.2 Flowable Powder
2.2.3 Sprayable Powder
2.2.4 Others

2.3 Matrix / Gel
2.3.1 Flowable Hemostatic Matrix
2.3.2 Gelatin Matrix
2.3.3 Thrombin Matrix
2.3.4 Others

2.4 Sheet / Pad
2.4.1 Cellulose Sheet
2.4.2 Collagen Pad
2.4.3 Fibrin Pad
2.4.4 Others

2.5 Liquid / Spray
2.5.1 Thrombin Solution
2.5.2 Hemostatic Spray
2.5.3 Sealant-Based Liquid Hemostats
2.5.4 Others

 

3. By Material

3.1 Gelatin
3.1.1 Porcine Gelatin
3.1.2 Bovine Gelatin
3.1.3 Synthetic Gelatin-Based Material
3.1.4 Others

3.2 Collagen
3.2.1 Bovine Collagen
3.2.2 Porcine Collagen
3.2.3 Recombinant Collagen
3.2.4 Others

3.3 Oxidized Regenerated Cellulose
3.3.1 Standard ORC
3.3.2 Advanced ORC
3.3.3 ORC Powder
3.3.4 Others

3.4 Thrombin
3.4.1 Human-Derived Thrombin
3.4.2 Bovine-Derived Thrombin
3.4.3 Recombinant Thrombin
3.4.4 Others

3.5 Fibrin
3.5.1 Human Fibrin
3.5.2 Fibrin Patch Material
3.5.3 Fibrin Sealant Material
3.5.4 Others

3.6 Others
3.6.1 Chitosan
3.6.2 Polysaccharide
3.6.3 Synthetic Polymers
3.6.4 Mineral-Based Materials

 

4. By Application

4.1 General Surgery
4.1.1 Abdominal Surgery
4.1.2 Gastrointestinal Surgery
4.1.3 Hernia Repair
4.1.4 Soft Tissue Surgery
4.1.5 Others

4.2 Cardiovascular Surgery
4.2.1 Coronary Artery Bypass Grafting
4.2.2 Valve Surgery
4.2.3 Vascular Repair
4.2.4 Aortic Surgery
4.2.5 Others

4.3 Orthopedic Surgery
4.3.1 Joint Replacement Surgery
4.3.2 Spine Surgery
4.3.3 Trauma Surgery
4.3.4 Bone Reconstruction
4.3.5 Others

4.4 Neurosurgery
4.4.1 Cranial Surgery
4.4.2 Spinal Neurosurgery
4.4.3 Tumor Resection
4.4.4 Others

4.5 Gynecological Surgery
4.5.1 Hysterectomy
4.5.2 Cesarean Section
4.5.3 Pelvic Surgery
4.5.4 Others

4.6 Urological Surgery
4.6.1 Prostate Surgery
4.6.2 Kidney Surgery
4.6.3 Bladder Surgery
4.6.4 Others

4.7 Dental & Oral Surgery
4.7.1 Tooth Extraction
4.7.2 Periodontal Surgery
4.7.3 Maxillofacial Surgery
4.7.4 Others

4.8 Trauma & Emergency Care
4.8.1 Accident & Injury Management
4.8.2 Emergency Bleeding Control
4.8.3 Military / Battlefield Trauma Care
4.8.4 Others

 

5. By Usability

5.1 Absorbable Hemostats
5.1.1 Gelatin Absorbable Hemostats
5.1.2 Collagen Absorbable Hemostats
5.1.3 Cellulose Absorbable Hemostats
5.1.4 Fibrin Absorbable Hemostats
5.1.5 Others

5.2 Non-Absorbable Hemostats
5.2.1 Hemostatic Dressings
5.2.2 External Hemostatic Pads
5.2.3 Trauma Hemostatic Products
5.2.4 Others

 

6. By End User

6.1 Hospitals
6.1.1 Public Hospitals
6.1.2 Private Hospitals
6.1.3 Multi-Specialty Hospitals
6.1.4 Surgical Hospitals

6.2 Ambulatory Surgical Centers
6.2.1 Single-Specialty ASCs
6.2.2 Multi-Specialty ASCs
6.2.3 Outpatient Surgery Centers
6.2.4 Others

6.3 Specialty Clinics
6.3.1 Dental Clinics
6.3.2 Orthopedic Clinics
6.3.3 ENT Clinics
6.3.4 Others

6.4 Trauma & Emergency Care Centers
6.4.1 Level I Trauma Centers
6.4.2 Level II Trauma Centers
6.4.3 Emergency Departments
6.4.4 Others

6.5 Military & Defense Medical Units
6.5.1 Field Hospitals
6.5.2 Military Trauma Units
6.5.3 Combat Emergency Care Units
6.5.4 Others

 

7. By Region

7.1 North America
7.1.1 U.S.
7.1.2 Canada
7.1.3 Mexico

7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 U.K.
7.2.4 Italy
7.2.5 Spain
7.2.6 Netherlands
7.2.7 Rest of Europe

7.3 Asia Pacific
7.3.1 China
7.3.2 India
7.3.3 Japan
7.3.4 South Korea
7.3.5 Australia
7.3.6 Malaysia
7.3.7 Indonesia
7.3.8 Vietnam
7.3.9 Rest of Asia Pacific

7.4 Latin America
7.4.1 Brazil
7.4.2 Argentina
7.4.3 Rest of Latin America

7.5 Middle East & Africa
7.5.1 Saudi Arabia
7.5.2 UAE
7.5.3 South Africa
7.5.4 Israel
7.5.5 Rest of Middle East & Africa

Top of Form

Global Hemostats Market – 100 Key Players in 10 Chapters

Chapter 01: Global Leading Hemostats Companies

  1. Johnson & Johnson Services, Inc. / Ethicon
  2. Baxter International Inc.
  3. Pfizer Inc.
  4. B. Braun SE
  5. Becton, Dickinson and Company
  6. Teleflex Incorporated
  7. Integra LifeSciences Holdings Corporation
  8. Medtronic plc
  9. Stryker Corporation
  10. Artivion, Inc. / CryoLife

Chapter 02: Advanced Surgical Hemostats & Sealants Companies

  1. CSL Behring
  2. Grifols, S.A.
  3. Octapharma AG
  4. Takeda Pharmaceutical Company Limited
  5. Kedrion Biopharma Inc.
  6. Advanced Medical Solutions Group plc
  7. Corza Medical
  8. Hemostasis, LLC
  9. Biom’up
  10. Marine Polymer Technologies, Inc.

Chapter 03: Topical Hemostatic Agents & Surgical Products Companies

  1. Medline Industries, LP
  2. Zimmer Biomet Holdings, Inc.
  3. Anika Therapeutics, Inc.
  4. Aroa Biosurgery Limited
  5. Tissuemed Ltd.
  6. Grena Ltd.
  7. LifeBond Ltd.
  8. Cresilon, Inc.
  9. RevMedx, Inc.
  10. Arch Therapeutics, Inc.

Chapter 04: Hemostatic Dressings & Trauma Care Companies

  1. HemCon Medical Technologies Inc.
  2. QuikClot / Z-Medica, LLC
  3. SAM Medical Products
  4. H&H Medical Corporation
  5. North American Rescue, LLC
  6. Safeguard Medical
  7. Celox Medical
  8. PerSys Medical
  9. TyTek Medical Inc.
  10. Tactical Medical Solutions, LLC

Chapter 05: Wound Care & Bleeding Control Product Companies

  1. Smith & Nephew plc
  2. 3M Company
  3. Mölnlycke Health Care AB
  4. ConvaTec Group plc
  5. Coloplast A/S
  6. Hollister Incorporated
  7. Paul Hartmann AG
  8. Lohmann & Rauscher GmbH & Co. KG
  9. DermaRite Industries, LLC
  10. Winner Medical Co., Ltd.

Chapter 06: Biologic, Fibrin & Plasma-Derived Hemostats Companies

  1. LFB S.A.
  2. Shanghai RAAS Blood Products Co., Ltd.
  3. China Biologic Products Holdings, Inc.
  4. Biotest AG
  5. Green Cross Corporation / GC Biopharma
  6. Hualan Biological Engineering Inc.
  7. Sanquin Plasma Products B.V.
  8. Japan Blood Products Organization
  9. ADMA Biologics, Inc.
  10. Kamada Ltd.

Chapter 07: Surgical Adhesives, Sealants & Biosurgery Companies

  1. CryoLife Europa Ltd.
  2. Polyganics B.V.
  3. Adhesys Medical GmbH
  4. Gecko Biomedical
  5. Tissium SA
  6. Sealantis Ltd.
  7. Cohera Medical, Inc.
  8. Meyer-Haake GmbH
  9. Peters Surgical
  10. Grena Biomed Limited

Chapter 08: Asia-Pacific Hemostats & Surgical Consumables Companies

  1. Terumo Corporation
  2. Nipro Corporation
  3. Olympus Corporation
  4. Gunze Limited
  5. JMS Co., Ltd.
  6. Daewoong Pharmaceutical Co., Ltd.
  7. Samyang Holdings Corporation
  8. Beijing Datsing Bio-Tech Co., Ltd.
  9. Hangzhou Singclean Medical Products Co., Ltd.
  10. Guangzhou Wondfo Biotech Co., Ltd.

Chapter 09: India, China & Emerging Market Surgical Product Companies

  1. Meril Life Sciences Pvt. Ltd.
  2. Healthium Medtech Limited
  3. Sutures India Pvt. Ltd.
  4. Dolphin Sutures
  5. Lotus Surgicals Pvt. Ltd.
  6. Unisur Lifecare Pvt. Ltd.
  7. Futura Surgicare Pvt. Ltd.
  8. Shandong Weigao Group Medical Polymer Co., Ltd.
  9. Lepu Medical Technology Co., Ltd.
  10. MicroPort Scientific Corporation

Chapter 10: Regional & Emerging Surgical / Wound Care Companies

  1. Unilene S.A.C. / Unilene
  2. Universal Sutures
  3. Assut Europe S.p.A.
  4. DemeTECH Corporation
  5. Internacional Farmacéutica S.A. de C.V.
  6. Betatech Medical
  7. Katsan Medical Devices
  8. Dolphin Hemostats
  9. Orion Sutures India Pvt. Ltd.
  10. Vitrex Medical A/S

Download Sample Request Form

Loading
Your message has been sent. Thank you!

Make an Inquiry

Loading
Your message has been sent. Thank you!

Ask for Discount

Loading
Your message has been sent. Thank you!
Frequently Asked Questions

Frequently Asked Questions

What are the key factors driving growth in the Global Hemostats Market?

The Global Hemostats Market is being driven by the rising volume of surgical procedures, increasing incidence of trauma-related injuries, growing demand for effective bleeding management solutions, and continuous advancements in absorbable and biologically active hemostatic technologies. Expanding healthcare infrastructure and the growing adoption of minimally invasive surgeries are further supporting market growth.

What is the current size of the Global Hemostats Market?

The Global Hemostats Market is estimated to be valued at approximately USD 3.92 billion in 2025. The market continues to witness strong demand from hospitals, ambulatory surgical centers, and trauma care facilities due to the increasing need for rapid bleeding control and improved surgical outcomes.

Which product segments are expected to create significant opportunities in the Hemostats Market?

Thrombin-based hemostats, gelatin-based hemostats, collagen-based hemostats, combination hemostats, and advanced fibrin-based products are expected to generate substantial growth opportunities. Increasing innovation in bioactive and absorbable hemostatic products is also creating new revenue streams for market participants.

How large is the Global Hemostats Market expected to become by 2035?

The Global Hemostats Market is projected to reach approximately USD 7.40 billion by 2035, growing at a CAGR of 6.55% during 2025–2035. Rising surgical volumes, expanding access to healthcare services, and increasing demand for advanced hemostatic solutions are expected to support long-term market expansion.

Which regions are expected to lead the Global Hemostats Market during the forecast period?

North America is expected to maintain a leading position due to its advanced healthcare infrastructure, high surgical procedure volume, and strong adoption of innovative surgical products. Meanwhile, Asia Pacific is anticipated to emerge as the fastest-growing region, supported by increasing healthcare investments, expanding hospital networks, and growing awareness of advanced bleeding management solutions.

<1-- -->